Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AARSD1,Alanyl-tRNA editing protein Aarsd1,24459,123,1.45 [1.11-1.90],0.0066229940893115
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACTA2,"Actin, aortic smooth muscle",24142,117,1.57 [1.20-2.04],0.0009170199693596
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACVRL1,Serine/threonine-protein kinase receptor R3,24380,122,4.23 [2.39-7.49],7.258854639405063e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADA2,Adenosine deaminase 2,24396,119,2.13 [1.49-3.03],2.924580908287077e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,20704,98,1.70 [1.25-2.32],0.0007850106781548
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,24142,117,2.87 [1.71-4.82],6.334914901477336e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,24773,121,3.57 [2.43-5.23],7.866554401932622e-11
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADGRD1,Adhesion G-protein coupled receptor D1,20839,104,0.45 [0.28-0.75],0.001922036187519
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADGRE1,Adhesion G protein-coupled receptor E1,21226,105,2.31 [1.72-3.09],2.060451916124748e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADGRE2,Adhesion G protein-coupled receptor E2,24670,121,2.99 [1.77-5.05],4.316218568437162e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADGRE5,Adhesion G protein-coupled receptor E5,24733,122,2.90 [1.86-4.52],2.571913963786694e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AGRN,Agrin,24670,121,2.01 [1.31-3.10],0.0014120350597948
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AHNAK,Neuroblast differentiation-associated protein AHNAK,20726,100,2.07 [1.31-3.25],0.0016674518742412
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AMOTL2,Angiomotin-like protein 2,21134,104,1.47 [1.11-1.96],0.0073827206381162
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AP2B1,AP-2 complex subunit beta,20725,96,1.55 [1.15-2.09],0.0035584164007235
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,24459,123,1.53 [1.18-1.97],0.0011084299052048
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ASGR1,Asialoglycoprotein receptor 1,24421,122,2.24 [1.39-3.62],0.0008897491548112
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATRAID,All-trans retinoic acid-induced differentiation factor,21226,105,1.55 [1.18-2.05],0.0016641536252241
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",B2M,Beta-2-microglobulin,21343,105,1.60 [1.30-1.97],8.770000853698728e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",B4GALT1,"Beta-1,4-galactosyltransferase 1",24670,121,2.94 [1.71-5.06],9.69462462965782e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BAG4,BAG family molecular chaperone regulator 4,20704,98,1.63 [1.20-2.21],0.0015762356774732
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BAG6,Large proline-rich protein BAG6,24142,117,1.77 [1.16-2.70],0.0078146288211884
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,23987,116,1.42 [1.12-1.78],0.0031027827250066
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BAMBI,BMP and activin membrane-bound inhibitor homolog,23987,116,2.42 [1.64-3.57],9.033170843264243e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BAP18,Chromatin complexes subunit BAP18,21260,104,1.34 [1.12-1.61],0.0017624574538233
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BCL2,Apoptosis regulator Bcl-2,21226,105,1.98 [1.68-2.32],1.870100782821239e-16
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BCL2L15,Bcl-2-like protein 15,20704,98,1.47 [1.16-1.86],0.0011969550547068
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BGN,Biglycan,23954,116,1.21 [1.06-1.38],0.0052234979212038
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,20704,98,1.71 [1.21-2.42],0.0021863711858482
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BSG,Basigin,24830,124,3.42 [1.57-7.47],0.0020000433990072
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BST2,Bone marrow stromal antigen 2,24812,122,1.38 [1.08-1.77],0.0095976380676298
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BTN2A1,Butyrophilin subfamily 2 member A1,24670,121,4.79 [2.88-7.97],1.720697669143049e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BTN3A2,Butyrophilin subfamily 3 member A2,24568,123,2.10 [1.52-2.91],7.661912329218118e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C19orf12,Protein C19orf12,23999,120,1.30 [1.07-1.58],0.0073622532195826
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C1QA,Complement C1q subcomponent subunit A,24748,124,4.24 [2.25-7.98],7.773238059442873e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,20839,104,0.56 [0.36-0.86],0.0080529625899973
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C1RL,Complement C1r subcomponent-like protein,21307,105,4.99 [1.96-12.68],0.000735258494799
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C2CD2L,Phospholipid transfer protein C2CD2L,23952,120,1.49 [1.15-1.93],0.0026217253398245
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C7,Complement component C7,20852,100,2.60 [1.46-4.64],0.0011758099996164
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CA12,Carbonic anhydrase 12,24459,123,1.76 [1.15-2.67],0.0085057612891598
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CANT1,Soluble calcium-activated nucleotidase 1,24519,122,5.05 [2.31-11.03],4.868856466950366e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CAPG,Macrophage-capping protein,24424,121,1.44 [1.13-1.83],0.0030528738438311
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL3,C-C motif chemokine 3,24568,123,1.27 [1.10-1.48],0.0013048461499795
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCNE1,G1/S-specific cyclin-E1,20704,98,1.22 [1.07-1.41],0.0040997770926466
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD14,Monocyte differentiation antigen CD14,24021,117,1.73 [1.19-2.51],0.0037501955018018
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD160,CD160 antigen,24879,125,1.69 [1.22-2.33],0.0014040688834435
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD177,CD177 antigen,24530,119,1.26 [1.09-1.47],0.0020832848388396
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD2,T-cell surface antigen CD2,20651,100,1.53 [1.13-2.08],0.0058882447209193
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD22,B-cell receptor CD22,24879,125,3.08 [2.25-4.22],2.005847611290179e-12
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD27,CD27 antigen,24624,121,3.89 [2.86-5.28],4.016767811515028e-18
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD274,Programmed cell death 1 ligand 1,24421,122,2.75 [2.01-3.76],2.596171262526241e-10
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD28,T-cell-specific surface glycoprotein CD28,23987,116,3.44 [2.60-4.55],4.116433713899241e-18
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD300A,CMRF35-like molecule 8,20839,104,2.86 [1.60-5.11],0.0003847346172001
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD300E,CMRF35-like molecule 2,24719,120,2.82 [1.99-4.00],5.755023651515545e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD300LF,CMRF35-like molecule 1,24795,121,1.61 [1.20-2.17],0.0016938890694177
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,24459,123,2.30 [1.39-3.80],0.0011663402514553
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD3E,T-cell surface glycoprotein CD3 epsilon chain,20915,101,1.47 [1.11-1.96],0.0080005040920545
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD4,T-cell surface glycoprotein CD4,24524,123,1.74 [1.18-2.55],0.0050714655099125
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD48,CD48 antigen,24635,121,3.08 [1.82-5.22],2.954324054530692e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD5,T-cell surface glycoprotein CD5,24764,121,3.31 [2.28-4.81],3.2398526625566357e-10
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD59,CD59 glycoprotein,23648,113,2.41 [1.28-4.54],0.0063186251437325
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD5L,CD5 antigen-like,21230,102,2.23 [1.57-3.16],7.2635210871061e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD7,T-cell antigen CD7,20670,98,2.23 [1.61-3.09],1.2148992919930342e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD70,CD70 antigen,24568,123,3.54 [2.73-4.59],1.6513954819904244e-21
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD72,B-cell differentiation antigen CD72,20839,104,4.80 [3.38-6.80],1.217192013045746e-18
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD74,HLA class II histocompatibility antigen gamma chain,24812,122,4.16 [2.84-6.09],2.1587606088046138e-13
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD79B,B-cell antigen receptor complex-associated protein beta chain,24879,125,4.03 [3.21-5.06],3.135738194888857e-33
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD80,T-lymphocyte activation antigen CD80,21317,104,5.88 [4.39-7.89],2.3581964077242915e-32
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD83,CD83 antigen,24568,123,4.67 [3.19-6.84],2.2170599578388215e-15
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDCP1,CUB domain-containing protein 1,24421,122,1.82 [1.40-2.36],7.442597915679325e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDH3,Cadherin-3,24812,122,1.99 [1.31-3.02],0.0011974687382677
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDH5,Cadherin-5,24871,123,2.02 [1.24-3.28],0.0044188513598591
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,20915,101,1.55 [1.15-2.08],0.0042686624935274
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEBPA,CCAAT/enhancer-binding protein alpha,20704,98,1.66 [1.28-2.14],0.00011384268276
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CENPF,Centromere protein F,20915,101,1.53 [1.16-2.03],0.002938688373743
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEP85,Centrosomal protein of 85 kDa,23987,116,1.45 [1.15-1.82],0.001440674564768
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CFB,Complement factor B,20950,102,2.35 [1.32-4.18],0.0036893045130951
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CFC1,Cryptic protein,23987,116,1.52 [1.18-1.96],0.0010194905614369
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",21260,104,1.91 [1.35-2.69],0.0002155930453934
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CHRDL1,Chordin-like protein 1,24635,121,2.09 [1.26-3.47],0.0043055686154488
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CIT,Citron Rho-interacting kinase,20725,96,1.75 [1.32-2.33],0.000114642306184
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CKAP4,Cytoskeleton-associated protein 4,24741,123,3.09 [2.10-4.56],1.1549689321804097e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CKB,Creatine kinase B-type,21308,103,1.65 [1.21-2.25],0.0016342480652453
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLEC12A,C-type lectin domain family 12 member A,20704,98,3.00 [1.82-4.94],1.6768629362962783e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLEC14A,C-type lectin domain family 14 member A,24565,119,2.06 [1.24-3.41],0.0050744439328897
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLEC1A,C-type lectin domain family 1 member A,24142,117,2.67 [1.70-4.21],2.0948337320780635e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLEC5A,C-type lectin domain family 5 member A,24498,122,2.01 [1.20-3.36],0.0081629825489713
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLEC6A,C-type lectin domain family 6 member A,23987,116,1.74 [1.27-2.39],0.0005677746147002
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLSTN3,Calsyntenin-3,21260,104,2.02 [1.31-3.13],0.0015995155025241
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CNTN3,Contactin-3,24565,119,0.48 [0.30-0.77],0.0025985281028738
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COL18A1,Collagen alpha-1(XVIII) chain,24648,121,2.57 [1.29-5.12],0.0073108578781871
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COLEC12,Collectin-12,24550,121,3.44 [1.91-6.17],3.564463555454951e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CR2,Complement receptor type 2,24632,120,1.87 [1.33-2.63],0.0003331318848114
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRIP2,Cysteine-rich protein 2,24421,122,1.66 [1.14-2.40],0.0074207557063916
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRTAM,Cytotoxic and regulatory T-cell molecule,24421,122,3.04 [2.28-4.07],5.3665544902283876e-14
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CSF1,Macrophage colony-stimulating factor 1,24670,121,4.41 [2.62-7.43],2.2113579139397744e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CSF1R,Macrophage colony-stimulating factor 1 receptor,21324,106,1.71 [1.16-2.52],0.0064197388348278
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,24421,122,1.49 [1.21-1.84],0.0001838883561204
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CST5,Cystatin-D,24134,121,1.51 [1.14-2.00],0.0039675519771089
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTSL,Cathepsin L1,24589,123,3.21 [1.77-5.83],0.0001256970484961
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTSO,Cathepsin O,24879,125,2.04 [1.27-3.26],0.0032155858145811
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTSV,Cathepsin L2,24721,121,0.46 [0.31-0.69],0.0001648136442258
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTSZ,Cathepsin Z,24540,120,2.72 [1.68-4.40],5.083865398282973e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CWC15,Spliceosome-associated protein CWC15 homolog,21109,105,1.41 [1.15-1.72],0.0008655695492373
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CX3CL1,Fractalkine,24421,122,1.85 [1.20-2.85],0.0052919384950594
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CXCL10,C-X-C motif chemokine 10,24670,121,1.41 [1.16-1.71],0.0005653437753102
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CXCL11,C-X-C motif chemokine 11,24812,122,1.31 [1.10-1.56],0.002176486225069
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CXCL13,C-X-C motif chemokine 13,24812,122,1.79 [1.63-1.96],1.8567585602092062e-34
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CXCL9,C-X-C motif chemokine 9,24670,121,1.81 [1.54-2.14],1.0417306895991809e-12
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DBN1,Drebrin,20704,98,1.58 [1.16-2.15],0.0037949543780735
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",24624,121,1.77 [1.15-2.71],0.0092044702841633
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DCTPP1,dCTP pyrophosphatase 1,24589,123,4.23 [2.80-6.40],7.747489162009246e-12
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DDX58,Antiviral innate immune response receptor RIG-I,23987,116,1.49 [1.23-1.79],3.269114974941693e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DEFA1_DEFA1B,Neutrophil defensin 1,24050,118,1.42 [1.10-1.84],0.0068903210079659
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DGKZ,Diacylglycerol kinase zeta,24128,118,1.85 [1.28-2.67],0.0010429460805932
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DHPS,Deoxyhypusine synthase,21201,104,1.80 [1.39-2.34],1.022797384525411e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DLL1,Delta-like protein 1,24624,121,3.96 [2.43-6.44],3.214913187492439e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DNAJC21,DnaJ homolog subfamily C member 21,21260,104,1.71 [1.16-2.51],0.0062617785477688
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DSC2,Desmocollin-2,24267,118,3.13 [2.09-4.68],2.678706229822232e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DTNB,Dystrobrevin beta,21165,104,1.70 [1.22-2.37],0.0017465410072495
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DTX3,Probable E3 ubiquitin-protein ligase DTX3,24459,123,2.20 [1.24-3.92],0.0072780916264657
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EBI3_IL27,Interleukin-27,24763,121,2.66 [1.82-3.88],4.574140988628506e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EDA2R,Tumor necrosis factor receptor superfamily member 27,24795,121,2.79 [1.88-4.12],2.880009543323296e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EFCAB14,EF-hand calcium-binding domain-containing protein 14,21226,105,2.00 [1.28-3.10],0.0021436800198591
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EFNA1,Ephrin-A1,24521,119,2.80 [1.66-4.74],0.0001202722409395
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EFNA4,Ephrin-A4,24380,122,4.45 [2.99-6.62],1.7011867071213345e-13
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EGLN1,Egl nine homolog 1,24568,123,1.35 [1.11-1.64],0.0028351843841861
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,20726,100,1.68 [1.19-2.37],0.0034488283032617
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ELN,Elastin,21317,104,2.24 [1.33-3.78],0.0024690040076726
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EPHA2,Ephrin type-A receptor 2,23699,118,2.88 [1.86-4.47],2.3721502874084284e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EPHA4,Ephrin type-A receptor 4,20839,104,2.41 [1.26-4.62],0.0080487748239192
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EPHB4,Ephrin type-B receptor 4,24871,123,2.31 [1.28-4.15],0.0053595978372461
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EPHB6,Ephrin type-B receptor 6,24374,122,3.13 [1.91-5.12],5.557412304603294e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EZR,Ezrin,24812,122,2.82 [1.57-5.07],0.0005008356931259
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FAM3C,Protein FAM3C,24561,123,2.12 [1.25-3.58],0.0050976741644016
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FAS,Tumor necrosis factor receptor superfamily member 6,24780,122,1.63 [1.23-2.16],0.0007547503388235
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,21317,104,2.70 [2.23-3.27],2.0901062121945508e-24
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCER2,Low affinity immunoglobulin epsilon Fc receptor,24565,119,2.60 [2.11-3.20],2.365213991870046e-19
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCRL1,Fc receptor-like protein 1,24589,123,2.45 [1.76-3.41],9.186327326562068e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCRL2,Fc receptor-like protein 2,24771,124,3.07 [2.53-3.73],7.00313563519373e-30
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCRL3,Fc receptor-like protein 3,24128,118,1.82 [1.37-2.43],3.770223344106889e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCRL6,Fc receptor-like protein 6,24568,123,1.42 [1.12-1.81],0.0044164780697417
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCRLB,Fc receptor-like B,23987,116,1.53 [1.25-1.88],3.754295293429642e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGA,Fibrinogen alpha chain,20844,101,2.12 [1.20-3.77],0.0098489562772509
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGFBP2,Fibroblast growth factor-binding protein 2,21308,103,0.59 [0.41-0.86],0.0055006413555766
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FH,"Fumarate hydratase, mitochondrial",20657,98,1.27 [1.07-1.50],0.0056047822802842
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,23952,120,1.45 [1.16-1.82],0.0011264921025535
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FLRT2,Leucine-rich repeat transmembrane protein FLRT2,24421,122,2.03 [1.21-3.41],0.0073015158158944
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FLT3LG,Fms-related tyrosine kinase 3 ligand,24879,125,2.14 [1.35-3.38],0.0012161387581034
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,21201,104,1.76 [1.23-2.51],0.001831108865048
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FOLR1,Folate receptor alpha,24504,120,2.61 [1.55-4.37],0.0002904222215351
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FOLR2,Folate receptor beta,24812,122,2.05 [1.21-3.48],0.0076398434295002
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FOXJ3,Forkhead box protein J3,20704,98,1.55 [1.12-2.15],0.0077250029292816
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FSTL3,Follistatin-related protein 3,24514,120,2.03 [1.25-3.32],0.0045388213043395
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,24812,122,1.74 [1.23-2.46],0.0016495742248901
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GABARAP,Gamma-aminobutyric acid receptor-associated protein,21201,104,1.76 [1.38-2.24],4.691401390294227e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,20915,101,1.46 [1.18-1.80],0.0004156618826847
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GAL,Galanin peptides,24670,121,0.71 [0.55-0.91],0.0063742769750812
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,24459,123,2.57 [1.55-4.27],0.0002560869834426
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,24128,118,1.64 [1.13-2.38],0.0097026571007499
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GBP1,Guanylate-binding protein 1,21221,104,1.65 [1.30-2.10],3.372711385039925e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,20326,101,1.66 [1.27-2.16],0.0001864507910399
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",24459,123,2.74 [1.80-4.17],2.361873255128513e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GDF15,Growth/differentiation factor 15,24871,123,1.82 [1.46-2.26],7.420703135701404e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GDNF,Glial cell line-derived neurotrophic factor,23999,120,1.67 [1.15-2.44],0.0077387208777661
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GFRA1,GDNF family receptor alpha-1,24763,121,2.22 [1.27-3.88],0.005319075141153
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GIPC2,PDZ domain-containing protein GIPC2,21260,104,2.42 [1.43-4.08],0.000917879910406
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GLI2,Zinc finger protein GLI2,20704,98,1.63 [1.13-2.36],0.0088283341765868
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GM2A,Ganglioside GM2 activator,20804,101,1.66 [1.25-2.20],0.0004419475169017
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GOLM2,Protein GOLM2,24812,122,2.55 [1.35-4.82],0.0039199773034097
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GRN,Progranulin,24446,119,2.67 [1.49-4.78],0.0009945993881716
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GZMA,Granzyme A,24879,125,2.43 [1.74-3.39],1.8597314004792128e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GZMH,Granzyme H,24142,117,1.28 [1.09-1.50],0.0023716710201965
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HAVCR1,Hepatitis A virus cellular receptor 1,24764,121,1.41 [1.10-1.80],0.0065717242000579
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HAVCR2,Hepatitis A virus cellular receptor 2,24565,119,2.33 [1.55-3.50],5.283857660459036e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HDAC8,Histone deacetylase 8,20704,98,1.39 [1.15-1.68],0.0007848986026013
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HDGFL2,Hepatoma-derived growth factor-related protein 2,21260,104,1.46 [1.15-1.86],0.0018918035985595
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HIP1R,Huntingtin-interacting protein 1-related protein,21225,103,1.56 [1.27-1.91],2.574371378965255e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HLA-E,"HLA class I histocompatibility antigen, alpha chain E",24568,123,2.74 [1.72-4.37],2.3109012417718148e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HMOX2,Heme oxygenase 2,23999,120,1.42 [1.09-1.85],0.0097985098095001
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HNMT,Histamine N-methyltransferase,24299,122,1.75 [1.27-2.40],0.0005263865450793
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,20726,100,1.89 [1.31-2.73],0.000652093265999
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,24795,121,1.70 [1.17-2.47],0.0052740215437014
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HSDL2,Hydroxysteroid dehydrogenase-like protein 2,20726,100,1.83 [1.30-2.59],0.0006234647267567
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HSPA2,Heat shock-related 70 kDa protein 2,21201,104,1.64 [1.21-2.24],0.0016986139034737
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HYOU1,Hypoxia up-regulated protein 1,24871,123,2.91 [1.44-5.91],0.0030397822968947
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ICAM1,Intercellular adhesion molecule 1,24441,119,2.11 [1.25-3.55],0.0049960821960972
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ICAM3,Intercellular adhesion molecule 3,24871,123,6.05 [3.77-9.70],8.865238807190018e-14
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IFI30,Gamma-interferon-inducible lysosomal thiol reductase,20741,98,2.80 [1.94-4.04],3.2783727806649804e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,20915,101,1.68 [1.14-2.48],0.0090563483776476
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IFNAR1,Interferon alpha/beta receptor 1,21226,105,2.05 [1.19-3.52],0.0093257403444207
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IFNG,Interferon gamma,24128,118,1.21 [1.05-1.39],0.007645064041029
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IFNGR1,Interferon gamma receptor 1,24670,121,2.94 [1.78-4.85],2.3975161728099683e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IFNL1,Interferon lambda-1,23999,120,1.65 [1.23-2.21],0.000843415036645
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IFNLR1,Interferon lambda receptor 1,24568,123,1.93 [1.49-2.51],7.574851785123887e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGDCC4,Immunoglobulin superfamily DCC subclass member 4,21308,103,0.40 [0.24-0.69],0.0008917322229315
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGFBP2,Insulin-like growth factor-binding protein 2,24824,123,1.48 [1.15-1.91],0.0027047801189654
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGFBP4,Insulin-like growth factor-binding protein 4,24243,117,1.87 [1.33-2.64],0.0003354436572474
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGLON5,IgLON family member 5,20560,100,1.25 [1.08-1.44],0.0022231944625696
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IKZF2,Zinc finger protein Helios,23987,116,1.20 [1.05-1.37],0.007928466779967
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL10,Interleukin-10,24128,118,1.50 [1.33-1.69],6.607377495700934e-11
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL10RA,Interleukin-10 receptor subunit alpha,24128,118,1.37 [1.15-1.63],0.0004239130331192
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL10RB,Interleukin-10 receptor subunit beta,24670,121,2.45 [1.72-3.49],7.902701394230918e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL12A_IL12B,Interleukin-12,24459,123,1.91 [1.59-2.30],4.0901461305294335e-12
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL12B,Interleukin-12 subunit beta,24879,125,2.65 [2.01-3.50],7.16890817171857e-12
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL12RB1,Interleukin-12 receptor subunit beta-1,24128,118,2.63 [1.86-3.72],4.815862314152208e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL15RA,Interleukin-15 receptor subunit alpha,24128,118,2.87 [1.84-4.48],3.3512069843022647e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL18,Interleukin-18,24459,121,1.92 [1.44-2.57],7.897641809784154e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL18BP,Interleukin-18-binding protein,24632,120,3.18 [2.14-4.73],9.483661241165472e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL18R1,Interleukin-18 receptor 1,24879,125,2.10 [1.34-3.29],0.0011303781556094
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL1R1,Interleukin-1 receptor type 1,24521,119,3.04 [1.71-5.39],0.0001487796544554
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL2RA,Interleukin-2 receptor subunit alpha,24408,121,3.30 [2.56-4.25],3.5041857626635336e-20
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL2RG,Cytokine receptor common subunit gamma,21201,104,1.54 [1.13-2.10],0.0062553749069695
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL32,Interleukin-32,24568,123,1.68 [1.22-2.30],0.0013637657071817
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL33,Interleukin-33,24128,118,1.70 [1.16-2.49],0.0067856781893384
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL4R,Interleukin-4 receptor subunit alpha,24568,123,2.01 [1.37-2.94],0.0003418447101592
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IMMT,MICOS complex subunit MIC60,21201,104,1.61 [1.21-2.14],0.0010380788535592
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",24142,117,1.25 [1.06-1.46],0.0065613434978828
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITGA6,Integrin alpha-6,24568,123,0.62 [0.44-0.87],0.0056214949815036
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITGB2,Integrin beta-2,24417,119,1.92 [1.17-3.13],0.0092197535254179
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITM2A,Integral membrane protein 2A,24568,123,1.53 [1.19-1.96],0.0009350197165902
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",23999,120,1.45 [1.12-1.87],0.004772572378117
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",JAM2,Junctional adhesion molecule B,24812,122,2.23 [1.25-4.00],0.0069599426351808
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",JCHAIN,Immunoglobulin J chain,24128,118,1.81 [1.42-2.31],1.372442860987499e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KCTD5,BTB/POZ domain-containing protein KCTD5,20840,99,1.65 [1.26-2.15],0.0002880922579161
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KIAA2013,Uncharacterized protein KIAA2013,21201,104,1.42 [1.15-1.74],0.0008896169864143
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,23987,116,1.41 [1.15-1.74],0.0011154666592147
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLK4,Kallikrein-4,24795,121,1.37 [1.08-1.73],0.0081553672388898
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLRB1,Killer cell lectin-like receptor subfamily B member 1,24879,125,2.28 [1.53-3.40],5.646236192975923e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLRD1,Natural killer cells antigen CD94,24879,125,1.96 [1.41-2.72],6.554089359090288e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLRK1,NKG2-D type II integral membrane protein,21260,104,2.00 [1.47-2.73],1.0819659443971755e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KRT19,"Keratin, type I cytoskeletal 19",24539,123,1.47 [1.19-1.83],0.0004659824105226
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LAG3,Lymphocyte activation gene 3 protein,24459,123,2.12 [1.71-2.62],8.204492943435093e-12
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,24550,121,2.04 [1.53-2.73],1.4663633615768015e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,24421,122,1.30 [1.10-1.53],0.0016704325666891
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LAMP3,Lysosome-associated membrane glycoprotein 3,24830,124,1.57 [1.17-2.10],0.0027520202747369
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LAMTOR5,Ragulator complex protein LAMTOR5,21201,104,1.59 [1.16-2.20],0.0043404712746167
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LAYN,Layilin,24374,122,2.53 [1.66-3.85],1.438825048096388e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LETM1,Mitochondrial proton/calcium exchanger protein,21284,104,1.63 [1.22-2.16],0.000801277948542
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LGALS1,Galectin-1,24589,123,1.77 [1.15-2.73],0.0096451635679955
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LGALS3,Galectin-3,24630,121,2.49 [1.57-3.94],0.0001005818052863
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LGALS9,Galectin-9,24546,120,4.73 [3.16-7.07],3.517573631332925e-14
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LIF,Leukemia inhibitory factor,23999,120,1.47 [1.20-1.80],0.0002491448743161
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,24565,119,2.23 [1.39-3.60],0.0009781636019674
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,24561,123,2.22 [1.39-3.57],0.0008966946081031
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,24871,123,2.80 [1.59-4.93],0.0003538199223574
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,24733,122,2.12 [1.33-3.39],0.0017083176356809
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,24128,118,2.53 [1.79-3.58],1.6338049157460805e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LMNB1,Lamin-B1,21181,105,1.37 [1.10-1.70],0.0044907923667592
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LMNB2,Lamin-B2,21260,104,3.37 [2.32-4.89],1.7254491593695798e-10
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LRG1,Leucine-rich alpha-2-glycoprotein,21343,105,3.20 [1.88-5.44],1.675236322524874e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,24732,121,3.00 [1.99-4.51],1.3245672018660813e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LRRC25,Leucine-rich repeat-containing protein 25,24459,123,1.65 [1.18-2.31],0.0034039158524649
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LTA,Lymphotoxin-alpha,24568,123,2.28 [1.73-2.99],3.2740393967520363e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LTBP2,Latent-transforming growth factor beta-binding protein 2,24871,123,2.80 [1.76-4.47],1.4783030558574782e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LTBP3,Latent-transforming growth factor beta-binding protein 3,23987,116,1.45 [1.17-1.80],0.0007035108725068
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LTBR,Tumor necrosis factor receptor superfamily member 3,24410,120,3.52 [2.17-5.71],3.5512289865916945e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LY6D,Lymphocyte antigen 6D,24408,119,1.94 [1.37-2.73],0.0001606101970297
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LY9,T-lymphocyte surface antigen Ly-9,24340,121,6.57 [4.25-10.16],2.4507284072399898e-17
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LY96,Lymphocyte antigen 96,24421,122,1.82 [1.27-2.62],0.0011173017877744
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LYPD8,Ly6/PLAUR domain-containing protein 8,23987,116,1.46 [1.17-1.82],0.0008466675985621
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",M6PR,Cation-dependent mannose-6-phosphate receptor,20726,100,1.57 [1.14-2.17],0.0060225027565659
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,24343,122,1.60 [1.33-1.91],3.582496263231413e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",20726,100,3.70 [1.79-7.64],0.0004121076755853
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MARCO,Macrophage receptor MARCO,24589,123,4.21 [2.30-7.71],3.254670844634581e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MATN2,Matrilin-2,24594,121,2.27 [1.34-3.85],0.0023622430187866
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MB,Myoglobin,24871,123,1.49 [1.16-1.91],0.0016288056035833
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MERTK,Tyrosine-protein kinase Mer,24879,125,2.25 [1.24-4.09],0.0075000606555484
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MILR1,Allergin-1,24128,118,1.64 [1.22-2.20],0.0010589671769515
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MKI67,Proliferation marker protein Ki-67,20704,98,1.59 [1.23-2.05],0.0003809141390278
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MMP12,Macrophage metalloelastase,24619,121,1.64 [1.23-2.18],0.0008326161648094
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MORC3,MORC family CW-type zinc finger protein 3,21260,104,1.84 [1.19-2.86],0.0063878779156456
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MPO,Myeloperoxidase,24565,119,1.59 [1.19-2.12],0.001679317587823
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",21260,104,1.90 [1.17-3.09],0.0097264424812088
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MZB1,Marginal zone B- and B1-cell-specific protein,24629,121,1.49 [1.11-2.02],0.0090638237000652
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NAGA,Alpha-N-acetylgalactosaminidase,20670,98,1.42 [1.16-1.74],0.0007411518795874
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NAGK,N-acetyl-D-glucosamine kinase,20687,99,1.58 [1.17-2.14],0.002938727335282
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NBL1,Neuroblastoma suppressor of tumorigenicity 1,24624,121,2.21 [1.21-4.01],0.0094822220436764
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,21226,105,2.10 [1.28-3.46],0.0032746431501872
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NDRG1,Protein NDRG1,23999,120,1.33 [1.15-1.54],0.0001054840722451
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NECTIN2,Nectin-2,24561,123,3.05 [1.87-4.95],6.874068311636254e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NEDD9,Enhancer of filamentation 1,20704,98,1.65 [1.14-2.40],0.0085795095662901
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NEFL,Neurofilament light polypeptide,23922,120,1.75 [1.29-2.39],0.0003776890854418
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NELL2,Protein kinase C-binding protein NELL2,24670,121,2.07 [1.23-3.50],0.006478445401166
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NFASC,Neurofascin,24879,125,2.65 [1.57-4.47],0.0002801595791865
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NHLRC3,NHL repeat-containing protein 3,20354,102,3.79 [2.07-6.95],1.62599008955896e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NMI,N-myc-interactor,21114,104,1.44 [1.15-1.81],0.0015393489021608
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NOS1,"Nitric oxide synthase, brain",23999,120,1.74 [1.37-2.19],3.6128754665041776e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NOS3,"Nitric oxide synthase, endothelial",23999,120,2.12 [1.85-2.42],3.8299384222295555e-28
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NOTCH1,Neurogenic locus notch homolog protein 1,24871,123,5.03 [2.04-12.40],0.0004425420763655
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NOTCH3,Neurogenic locus notch homolog protein 3,24871,123,1.95 [1.25-3.04],0.0033046234188424
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NPC2,NPC intracellular cholesterol transporter 2,20955,101,2.36 [1.63-3.41],5.282805512680337e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NPDC1,Neural proliferation differentiation and control protein 1,24589,123,2.34 [1.59-3.42],1.3408354372373882e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NRCAM,Neuronal cell adhesion molecule,24589,123,2.95 [1.76-4.97],4.479567709583645e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NT5C1A,Cytosolic 5'-nucleotidase 1A,21260,104,1.73 [1.21-2.46],0.0023371266624399
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NTproBNP,N-terminal prohormone of brain natriuretic peptide,24589,123,1.41 [1.22-1.63],3.4991364539894256e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,20726,100,1.81 [1.21-2.70],0.003606466987328
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NUDT15,Nucleotide triphosphate diphosphatase NUDT15,20651,100,1.47 [1.17-1.85],0.0008755509486103
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NUP50,Nuclear pore complex protein Nup50,20651,100,1.82 [1.26-2.62],0.0012796465029228
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OCLN,Occludin,21284,104,2.01 [1.40-2.90],0.0001589660368851
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OGFR,Opioid growth factor receptor,24459,123,2.34 [1.51-3.62],0.000134809484446
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ORM1,Alpha-1-acid glycoprotein 1,21269,105,4.43 [2.07-9.44],0.0001194557743248
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OSBPL2,Oxysterol-binding protein-related protein 2,21260,104,1.60 [1.22-2.11],0.0007946182711873
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OSCAR,Osteoclast-associated immunoglobulin-like receptor,24594,121,1.98 [1.22-3.21],0.0057792550766242
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",20726,100,1.43 [1.11-1.85],0.0060606297234264
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PAGR1,PAXIP1-associated glutamate-rich protein 1,20726,100,1.56 [1.14-2.15],0.0059563597238054
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PAPPA,Pappalysin-1,24128,118,0.57 [0.40-0.80],0.0014011499725675
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PCDH17,Protocadherin-17,24589,123,2.07 [1.36-3.14],0.0006969241970751
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDCD1,Programmed cell death protein 1,24760,121,5.39 [4.45-6.54],9.699238304643684e-66
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDIA3,Protein disulfide-isomerase A3,20839,104,1.74 [1.17-2.60],0.0063217443196165
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",23987,116,1.34 [1.08-1.68],0.009190405667753
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PGF,Placenta growth factor,24879,125,2.43 [1.81-3.26],3.303603668445255e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,24565,119,2.75 [1.63-4.64],0.00014396196869
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PILRA,Paired immunoglobulin-like type 2 receptor alpha,24565,119,1.83 [1.23-2.70],0.0025908133119353
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PILRB,Paired immunoglobulin-like type 2 receptor beta,24589,123,1.56 [1.15-2.12],0.0039698334358392
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PKD2,Polycystin-2,20651,100,1.48 [1.14-1.92],0.0028504672589241
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLAUR,Urokinase plasminogen activator surface receptor,24385,120,3.37 [1.96-5.78],1.014665199637439e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLXNB2,Plexin-B2,24753,122,3.51 [1.92-6.40],4.274905723663506e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",24459,123,1.74 [1.32-2.29],7.613390868889628e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPM1B,Protein phosphatase 1B,20704,98,1.32 [1.07-1.63],0.0094048597496665
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,21284,104,1.80 [1.26-2.57],0.0011508398757085
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRCP,Lysosomal Pro-X carboxypeptidase,24705,121,2.17 [1.38-3.41],0.0008058953894366
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRRT3,Proline-rich transmembrane protein 3,20726,100,2.14 [1.34-3.41],0.0014429970603538
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRTN3,Myeloblastin,23944,117,1.57 [1.22-2.03],0.0005537875344712
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PSAP,Prosaposin,21116,102,2.49 [1.67-3.71],7.68471446086594e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PSMD1,26S proteasome non-ATPase regulatory subunit 1,21284,104,1.67 [1.26-2.20],0.0003474936971239
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PSME2,Proteasome activator complex subunit 2,24309,122,2.15 [1.42-3.25],0.0002974432823976
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTGDS,Prostaglandin-H2 D-isomerase,24363,119,2.32 [1.50-3.58],0.0001521857500968
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTK7,Inactive tyrosine-protein kinase 7,23999,120,1.93 [1.31-2.85],0.000885712630069
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTN,Pleiotrophin,24142,117,1.59 [1.19-2.12],0.0015873516555054
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTPRC,Receptor-type tyrosine-protein phosphatase C,21308,103,4.93 [2.72-8.95],1.5796993209083824e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PXN,Paxillin,23999,120,1.54 [1.24-1.91],0.0001053933034688
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",QPCT,Glutaminyl-peptide cyclotransferase,24569,120,3.18 [1.77-5.70],0.0001042221803598
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RBFOX3,RNA binding protein fox-1 homolog 3,21284,104,1.93 [1.44-2.58],9.41564046711094e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RBP5,Retinol-binding protein 5,24459,123,1.56 [1.22-1.99],0.0003212204952062
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RCC1,Regulator of chromosome condensation,21201,104,1.47 [1.17-1.83],0.0007319993356954
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RCOR1,REST corepressor 1,24142,117,1.38 [1.09-1.75],0.007016103729623
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",REG3A,Regenerating islet-derived protein 3-alpha,24871,123,1.43 [1.13-1.81],0.0027958558361495
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",REG4,Regenerating islet-derived protein 4,24594,121,1.54 [1.12-2.12],0.0079286279673841
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RELT,Tumor necrosis factor receptor superfamily member 19L,24565,119,3.46 [2.09-5.73],1.4880803757712585e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RETN,Resistin,24495,120,1.61 [1.16-2.22],0.004119591355906
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RFC4,Replication factor C subunit 4,21201,104,2.24 [1.26-3.98],0.0061990811511413
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RNASE6,Ribonuclease K6,21170,106,2.07 [1.46-2.93],4.232966565314546e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RNASET2,Ribonuclease T2,24749,121,3.10 [1.95-4.91],1.612987330609331e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RNF149,E3 ubiquitin-protein ligase RNF149,20726,100,3.41 [2.01-5.79],5.389742197751389e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RNF168,E3 ubiquitin-protein ligase RNF168,20704,98,1.53 [1.11-2.11],0.0095109893858803
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ROBO1,Roundabout homolog 1,24594,121,3.64 [2.02-6.56],1.809466689885793e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,24589,123,2.33 [1.41-3.84],0.0009800709910551
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RPGR,X-linked retinitis pigmentosa GTPase regulator,20725,96,1.63 [1.19-2.22],0.0021025408219734
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RRM2,Ribonucleoside-diphosphate reductase subunit M2,23987,116,1.64 [1.39-1.94],4.937562827413526e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SAFB2,Scaffold attachment factor B2,21284,104,1.86 [1.16-2.98],0.0095808296343218
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCARB2,Lysosome membrane protein 2,23950,118,3.15 [2.07-4.81],9.114142697598993e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SDC1,Syndecan-1,24589,123,2.10 [1.59-2.77],1.7511513055020532e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SDC4,Syndecan-4,24589,123,0.59 [0.42-0.82],0.0016726287787268
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SELL,L-selectin,21343,105,2.82 [1.45-5.46],0.0021354578262248
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SEMA3F,Semaphorin-3F,24589,123,2.46 [1.36-4.43],0.0028506260868778
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SEMA3G,Semaphorin-3G,20839,104,1.70 [1.16-2.47],0.0058757951324459
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SEMA4D,Semaphorin-4D,24812,122,2.03 [1.19-3.47],0.0096252649778792
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SEMA7A,Semaphorin-7A,24780,122,4.64 [3.23-6.67],1.0796055544772467e-16
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SEPTIN7,Septin-7,20915,101,1.43 [1.13-1.81],0.0029746718635003
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SEPTIN8,Septin-8,21212,104,2.05 [1.32-3.18],0.001464167331818
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINA9,Serpin A9,24337,123,1.84 [1.52-2.22],4.0425650161675804e-10
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINB8,Serpin B8,24879,125,1.42 [1.18-1.70],0.0001504337897252
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SH3GL3,Endophilin-A3,20787,101,0.77 [0.63-0.93],0.0071846338994452
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SHISA5,Protein shisa-5,21308,103,2.78 [1.81-4.28],3.274015633739586e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIGLEC1,Sialoadhesin,24670,121,1.76 [1.24-2.50],0.0016191097245906
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIGLEC10,Sialic acid-binding Ig-like lectin 10,24568,123,5.51 [3.85-7.90],1.3087138580488023e-20
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIGLEC6,Sialic acid-binding Ig-like lectin 6,24795,121,2.72 [1.95-3.79],3.415312354390409e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIGLEC8,Sialic acid-binding Ig-like lectin 8,20726,100,1.91 [1.28-2.86],0.0016748166155249
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIRPB1,Signal-regulatory protein beta-1,24499,121,2.28 [1.61-3.23],3.254286357770104e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLAMF6,SLAM family member 6,23987,116,2.15 [1.53-3.02],1.0008093870363203e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLAMF8,SLAM family member 8,23987,116,2.76 [2.05-3.71],2.456501162429913e-11
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLITRK6,SLIT and NTRK-like protein 6,24142,117,1.81 [1.21-2.71],0.0039063136932203
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SMPD1,Sphingomyelin phosphodiesterase,24693,122,1.63 [1.21-2.18],0.0012206912218574
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SMPD3,Sphingomyelin phosphodiesterase 3,20704,98,1.33 [1.07-1.66],0.0091255110298923
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SNRPB2,U2 small nuclear ribonucleoprotein B'',21260,104,1.40 [1.12-1.75],0.0035438777270228
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SORCS2,VPS10 domain-containing receptor SorCS2,23987,116,2.33 [1.49-3.65],0.0002150376189982
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPINK4,Serine protease inhibitor Kazal-type 4,24568,123,1.61 [1.29-2.02],3.3424021524230935e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPINT1,Kunitz-type protease inhibitor 1,24478,119,2.27 [1.39-3.73],0.001112160065994
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",20704,98,1.67 [1.23-2.27],0.0009575727869344
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPRR3,Small proline-rich protein 3,21260,104,1.42 [1.10-1.84],0.0080092753077481
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STC1,Stanniocalcin-1,24812,122,1.99 [1.45-2.72],2.1360698262624783e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STX3,Syntaxin-3,21260,104,1.64 [1.20-2.24],0.0018279479176802
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SUSD4,Sushi domain-containing protein 4,21201,104,1.59 [1.14-2.21],0.0060295282666976
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SWAP70,Switch-associated protein 70,21226,105,1.85 [1.36-2.52],8.442722055247216e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TCOF1,Treacle protein,21317,104,2.40 [1.77-3.24],1.5553435456183348e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TDP1,Tyrosyl-DNA phosphodiesterase 1,21201,104,1.37 [1.14-1.64],0.0006073328517225
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TGFBR2,TGF-beta receptor type-2,24624,121,2.07 [1.32-3.27],0.0016520814827345
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",THBD,Thrombomodulin,24589,123,2.67 [1.56-4.56],0.0003275006836882
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",THOP1,Thimet oligopeptidase,24490,123,2.17 [1.40-3.37],0.0005089242519878
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TIGAR,"Fructose-2,6-bisphosphatase TIGAR",23952,120,1.64 [1.25-2.15],0.000315281913383
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TIGIT,T-cell immunoreceptor with Ig and ITIM domains,20915,101,2.11 [1.74-2.56],3.0476934237209524e-14
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TINAGL1,Tubulointerstitial nephritis antigen-like,24515,123,3.72 [1.93-7.17],8.694972781371142e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TK1,"Thymidine kinase, cytosolic",20915,101,1.70 [1.33-2.16],2.0252185752801573e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TLR1,Toll-like receptor 1,20704,98,3.03 [1.84-4.99],1.3479814777712997e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNC,Tenascin,24632,120,1.56 [1.12-2.16],0.0076614612793212
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNF,Tumor necrosis factor,24101,117,1.88 [1.58-2.24],1.8927281786019765e-12
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFAIP2,Tumor necrosis factor alpha-induced protein 2,21226,105,1.51 [1.14-2.01],0.0042625671321482
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,24421,122,2.24 [1.62-3.10],9.818670592051712e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,24421,122,1.43 [1.22-1.67],8.93648216648876e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,24879,125,1.90 [1.28-2.82],0.0015068379687751
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,24594,121,4.48 [3.38-5.93],9.9493893934312e-26
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,24128,118,2.86 [2.36-3.47],5.1529854384757466e-27
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF14,Tumor necrosis factor receptor superfamily member 14,24594,121,2.96 [1.84-4.75],7.76426915819651e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF17,Tumor necrosis factor receptor superfamily member 17,20839,104,3.47 [2.22-5.43],4.61614905078301e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF19,Tumor necrosis factor receptor superfamily member 19,24795,121,1.97 [1.22-3.18],0.0057524073943611
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,24565,119,3.04 [1.88-4.92],6.171339425367147e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,24565,119,1.84 [1.50-2.25],4.192390638380098e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF4,Tumor necrosis factor receptor superfamily member 4,24830,124,6.19 [4.80-8.00],1.725176777037564e-44
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,24421,122,1.57 [1.24-2.00],0.0002064016131328
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF8,Tumor necrosis factor receptor superfamily member 8,24812,122,3.20 [2.55-4.01],8.025806543417056e-24
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF9,Tumor necrosis factor receptor superfamily member 9,24421,122,3.95 [3.41-4.58],3.926517757148325e-74
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFSF10,Tumor necrosis factor ligand superfamily member 10,24879,125,2.21 [1.21-4.03],0.0097276946842777
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFSF8,Tumor necrosis factor ligand superfamily member 8,21308,103,3.04 [2.08-4.43],7.364991298453784e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNXB,Tenascin-X,24565,119,0.39 [0.21-0.71],0.0022439020383877
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TPK1,Thiamin pyrophosphokinase 1,21317,104,3.18 [1.71-5.91],0.0002486035567692
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TPR,Nucleoprotein TPR,20651,100,1.44 [1.14-1.80],0.0017293482261056
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TREM2,Triggering receptor expressed on myeloid cells 2,24550,121,1.60 [1.20-2.14],0.0012376628589957
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TSC1,Hamartin,20704,98,1.34 [1.13-1.59],0.0006586847995078
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,21317,104,1.58 [1.19-2.10],0.0015147058776018
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ULBP2,UL16-binding protein 2,24421,122,2.10 [1.43-3.08],0.0001587723637438
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VCAM1,Vascular cell adhesion protein 1,24603,120,4.84 [3.02-7.74],4.9639831457243246e-11
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VSIG2,V-set and immunoglobulin domain-containing protein 2,21201,104,1.54 [1.16-2.05],0.0030176515122487
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VSIG4,V-set and immunoglobulin domain-containing protein 4,24527,119,2.29 [1.59-3.31],9.779808131651223e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",WARS,"Tryptophan--tRNA ligase, cytoplasmic",24565,119,2.08 [1.37-3.16],0.000598818759871
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",WFDC2,WAP four-disulfide core domain protein 2,23282,114,2.54 [1.80-3.59],1.3665207649454898e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",WNT9A,Protein Wnt-9a,24128,118,1.97 [1.26-3.09],0.0030080873321488
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",XCL1,Lymphotactin,24795,121,1.38 [1.10-1.72],0.0048503937311878
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ZBP1,Z-DNA-binding protein 1,20704,98,1.97 [1.55-2.51],3.9451669395678576e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ZBTB17,Zinc finger and BTB domain-containing protein 17,24142,117,1.88 [1.48-2.39],2.667157798006988e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ZHX2,Zinc fingers and homeoboxes protein 2,21260,104,1.74 [1.33-2.28],5.126224276538162e-05
